The North America cell therapy instruments market was valued at US$ 5,546.84 million in 2019 and is projected to reach US$ 14,806.33 million by 2027; it is expected to grow at a CAGR of 13.4% during the forecast period.
The rise in cell therapy transplantation's, growing numbers of research and development activities and rising investments for building cell and gene therapy manufacturing plants will drive the growth of the North America cell therapy instruments market during the forecast period. However, the high cost of low success rate and cell-based research are expected to restrain North America Cell Therapy Instruments market growth during the forecast period.
Cell therapy is the therapy involving administration of somatic cell preparations by injecting or grafting into the patient’s body for the treatment of diseases or traumatic damages. Various instruments are used to carry out cell therapy to cure diabetes, neurological disorders, related injuries, some types of cancer, bones and joints and genetic disorders.
The increasing research and development in cell therapy have led to extraordinary therapeutic developments in cell therapy instruments to improve immune system and efficiently treat genetic disorders. Various market players provide several consumables such as reagents kits and enzymes and many companies offer instruments, equipment, and software to conduct a wide range of cell therapy processes.
The use of equipment is important for the production of cell therapies such as NSC, PSC, MSC, T cells and HSC, . These cell therapy products are derived from animals or human cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies helps in preventing contamination and allows scaling up the transplantation. For instance, companies such as Hitachi Chemical Advanced Therapeutics Solutions, Corning Incorporated, Thermo Fisher Scientific Inc., Miltenyi Biotec, LLC, Invetech and Cytiva (General Electric Company) have introduced various equipment and consumables for the cell therapy.
Across North America, various healthcare research centers were working only for research on COVID 19 therapeutics. Additionally, during the initial phase of COVID-19 crisis, due to lockdown and supply chain disruptions the demand for cell therapy instruments was disrupted owing to change in customer behaviors. However, in long run cell therapy instruments market will have significant growth prospects. For instance, lack of definitive therapy offers significant opportunities for cell therapy instrumentation market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients.
North America Cell Therapy Instruments Market Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Cell Therapy Instruments Market
By Product
- Consumables
- Equipment
- Single-Use Equipment
- Cell Processing Equipment
- Other Equipment
- Systems and Software
By Cell Type
- Human Cells
- Differentiated Cells
- Stem Cells
- Animal Cells
By Process
- Cell Processing
- Process Monitoring and Quality Control
- Cell Preservation, Distribution, and Handling
By End User
- Research Institutes
- Life Science Research Companies
- Other End Users
By Geography
- US
- Canada
- Mexico
List of Companies
- STEMCELL Technologies Inc.
- Miltenyi Biotec
- General Electric Company
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Cell Type, Process, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Cell Therapy Instruments Market – By Product
1.3.2 North America Cell Therapy Instruments Market – By Cell Type
1.3.3 North America Cell Therapy Instruments Market – By Process
1.3.4 North America Cell Therapy Instruments Market – By End User
1.3.5 Cell Therapy Instruments Market – By Geography
2. Cell Therapy Instruments Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Cell Therapy Instruments– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. Cell Therapy Instruments Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Developments in Cell Therapy Manufacturing
5.1.2 Rising Number of Approvals for Cell-based Therapies
5.2 Market Restraints
5.2.1 High Cost Of Cell Therapy Production and Cell Therapy
5.3 Market Opportunities
5.3.1 Growth Opportunities in Developing Regions
5.4 Future Trends
5.4.1 Shift Toward Automated Manufacturing
5.5 Impact Analysis
6. Cell Therapy Instruments Market – North America Analysis
6.1 North America Cell Therapy Instrument Marker Revenue Forecast And Analysis
7. Cell Therapy Instruments Market Analysis – By Product
7.1 Overview
7.2 Cell Therapy Instruments Market Revenue Share, by Product (2019 and 2027)
7.3 Consumables
7.3.1 Overview
7.3.2 Consumables: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Equipment
7.4.1 Overview
7.4.2 Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
7.4.3 Single–use Equipment
7.4.3.1 Overview
7.4.3.2 Single–use Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
7.4.4 Cell Processing Equipment
7.4.4.1 Overview
7.4.4.2 Cell Processing Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
7.4.5 Other Equipment
7.4.5.1 Overview
7.4.5.2 Other Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Systems and Software
7.5.1 Overview
7.5.2 Systems and Software Segment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
7.6
8. Cell Therapy Instruments Market Analysis – By Cell Type
8.1 Overview
8.2 Cell Therapy Instruments Market Revenue Share, by Cell Type (2019 and 2027)
8.3 Human Cells
8.3.1 Human Cells: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
8.3.2 Differentiated Cells
8.3.2.1 Overview
8.3.2.2 Differentiated Cells: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
8.3.3 Stem Cells
8.3.3.1 Overview
8.3.3.2 Stem Cells: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Animal Cells
8.4.1 Overview
8.4.2 Animal Cells : Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
9. Cell Therapy Instruments Market Analysis – By Process
9.1 Overview
9.2 Cell Therapy Instruments Market Revenue Share, by Process (2019 and 2027)
9.3 Cell Processing
9.3.1 Cell Processing: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Process Monitoring and Quality Control
9.4.1 Process Monitoring and Quality Control: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Cell Preservation, Distribution, and Handling
9.5.1 Cell Preservation, Distribution, and Handling: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
10. Cell Therapy Instruments Market Analysis – By End User
10.1 Overview
10.2 Cell Therapy Instruments Market Share, by End Users, 2019 and 2027, (%)
10.3 Research Institutes
10.3.1 Overview
10.3.2 Research Institutes: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Life Science Research Companies
10.4.1 Overview
10.4.2 Life Science Research Companies : Cell therapy instruments market – Revenue and Forecast to 2027 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Cell therapy instruments market – Revenue and Forecast to 2027 (US$ Million)
11. Cell Therapy Instruments Market Analysis And Forecast To 2027 – Geographical Analysis
11.1 North America: Cell Therapy Instruments Market
11.1.1 Overview
11.1.2 North America: Cell Therapy Instruments Market,- Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.3.1 North America: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.4 North America: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
11.1.4.1 North America: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.5 North America: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million)
11.1.6 North America: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7 North America: Cell Therapy Instruments Market, by Country, 2019 & 2027 (%)
11.1.8 US: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.8.2.1 US: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 US: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.3.1 US: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 US: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 US: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.9 Canada: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.9.2.1 Canada: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Canada: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.3.1 Canada: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Canada: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Canada: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.10 Mexico: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
11.1.10.2.1 Mexico: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Mexico: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.3.1 Mexico: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Mexico: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Mexico: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on North America Cell Therapy Instruments Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Lonza
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 General Electric Company
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Terumo Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BD
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Miltenyi Biotec
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 STEMCELL Technologies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Sartorius AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Danaher (Beckman Coulter, Inc.)
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million)
Table 6. North America: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. US: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. US: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
Table 10. US: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. US: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million
Table 12. US: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Canada: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Canada: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million
Table 18. Canada: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Cell Therapy Instruments Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Equipment Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Mexico: Cell Therapy Instruments Market, by Cell Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico: Human Cells Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Mexico: Cell Therapy Instruments Market, by Process – Revenue and Forecast to 2027 (USD Million
Table 24. Mexico: Cell Therapy Instruments Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 25. Glossary of Terms, Cell Therapy Instruments Market
LIST OF FIGURES
Figure 1. Cell Therapy Instruments Market Segmentation
Figure 2. Cell Therapy Instruments Market – By Geography
Figure 3. Cell Therapy Instruments Market Overview
Figure 4. Consumables Segment Held Largest Share of Cell Therapy Instruments Market
Figure 5. North America Cell Therapy Instruments Market – Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. Cell Therapy Instruments Market Impact Analysis of Driver and Restraints
Figure 8. North America Cell Therapy Instruments Market – Revenue Forecast And Analysis – 2019- 2027
Figure 9. Cell Therapy Instruments Market Revenue Share, by Product (2019 and 2027)
Figure 10. Consumables: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Single–use Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Cell Processing Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Other Equipment: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Systems and Software Segment : Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Cell Therapy Instruments Market Revenue Share, by Cell Type (2019 and 2027)
Figure 17. Human Cells: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Differentiated Cells: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Stem Cells: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Animal Cells : Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell Therapy Instruments Market Revenue Share, by Process (2019 and 2027)
Figure 22. Cell Processing: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Process Monitoring and Quality Control: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cell Preservation, Distribution, and Handling: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Cell Therapy Instruments Market Share, by End Users, 2019 and 2027, (%)
Figure 26. Research Institutes: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Life Science Research Companies: Cell therapy instruments market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Other End Users: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. North America: Cell Therapy Instruments Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. North America: Cell Therapy Instruments Market, Revenue and Forecast to 2027 (USD Million)
Figure 31. North America: Cell Therapy Instruments Market, by Country, 2019 & 2027 (%)
Figure 32. US: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Canada: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Mexico: Cell Therapy Instruments Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in North American Country Markets
- STEMCELL Technologies Inc.
- Miltenyi Biotec
- General Electric Company
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Cell Therapy Instruments Market
Oct 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Oct 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Oct 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)